Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures

Black, D. M., Cummings, S. R., Karpf, D. B., Cauley, J. A., Thompson, D. E., Nevitt, M. C., Bauer, D. C., Genant, H. K., Haskell, W. L., Marcus, R., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07088-2 · Cited by 3,846

Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures

Marshall, D., Johnell, O., & Wedel, H. (1996) · BMJ · doi:10.1136/bmj.312.7041.1254 · Cited by 3,709

Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene<SUBTITLE>Results From a 3-Year Randomized Clinical Trial</SUBTITLE>

Ettinger, B. (1999) · JAMA · doi:10.1001/jama.282.7.637 · Cited by 3,366

Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women With Postmenopausal Osteoporosis<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

Harris, S. T. (1999) · JAMA · doi:10.1001/jama.282.14.1344 · Cited by 2,475

Effect of Alendronate on Risk of Fracture in Women With Low Bone Density but Without Vertebral Fractures<SUBTITLE>Results From the Fracture Intervention Trial</SUBTITLE>

Cummings, S. R. (1998) · JAMA · doi:10.1001/jama.280.24.2077 · Cited by 2,277

Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis

Liberman, U. A., Weiss, S. R., Bröll, J., Minne, H. W., Quan, H., Bell, N. H., Rodriguez-Portales, J. A., Downs, R. W., Dequeker, J., Favus, M. J., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511303332201 · Cited by 2,276

Randomized Trial of the Effects of Risedronate on Vertebral Fractures in Women with Established Postmenopausal Osteoporosis

Reginster, J.-Y., Minne, H. W., Sorensen, O. H., Hooper, M., Roux, C., Brandi, M. L., Lund, B., Ethgen, D., Pack, S., Roumagnac, I., et al. (2000) · Osteoporosis International · doi:10.1007/s001980050010 · Cited by 1,580

A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study

Chesnut, C. H., Silverman, S., Andriano, K., Genant, H., Gimona, A., Harris, S., Kiel, D., LeBoff, M., Maricic, M., Miller, P., et al. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00490-3 · Cited by 1,122

Markers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective study

Garnero, P., Hausherr, E., Chapuy, M. C., Marcelli, C., Grandjean, H., Müller, C., Cormier, C., Bréart, G., Meunier, P. J., & Delmas, P. D. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650111021 · Cited by 984

Intermittent Cyclical Etidronate Treatment of Postmenopausal Osteoporosis

Watts, N. B., Harris, S. T., Genant, H. K., Wasnich, R. D., Miller, P. D., Jackson, R. D., Licata, A. A., Ross, P. D., Woodson, G. C., Yanover, M., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007123230201 · Cited by 947

Qué significa la calidad ósea

Mellibovsky, L., & Díez‐Pérez, A. (2006) · Seminarios de la Fundación Española de Reumatología · doi:10.1016/s1577-3566(06)75096-5 · Cited by 2

Sensitivity in statistical evaluation of biomarkers

Li, W., Qu, Y., & Kulkarni, P. M. (2013) · Statistics in Medicine · doi:10.1002/sim.5794 · Cited by 2

Effects of Yearly Zoledronic Acid 5mg on Bone Turnover Markers and Relation of PINP With Fracture Reduction in Postmenopausal Women With Osteoporosis

Clarke, B. L. (2010) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(10)79500-7 · Cited by 2

FACULTE MIXTE DE MEDECINE ET DE PHARMACIE DE ROUEN

Eltchaninoff, H., Lacroix, D., & Savoure, D. A. (2013) · Cited by 2

Optimizing the Skeletal Benefits of Mechanical Loading and Exercise

Warden, S. J., & Fuchs, R. K. (2011) · CRC Press eBooks · doi:10.1201/b11228-7 · Cited by 2

Selective Estrogen Receptor Modulators (SERMs)

Sambrook, P. N. (2006) · Elsevier eBooks · doi:10.1016/b978-0-323-03437-1.50022-1 · Cited by 2

Forecasting Postflight Hip Fracture Probability Using Probabilistic Modeling

Lewandowski, B. E., & Myers, J. G. (2018) · Journal of Biomechanical Engineering · doi:10.1115/1.4041164 · Cited by 2

PTH and PTHrP Analogs: Treatment of Osteoporosis

Tabacco, G., & Bilezikian, J. P. (2020) · Contemporary Endocrinology · doi:10.1007/978-3-319-69287-6_17 · Cited by 2

Monitoring Changes in Bone Density

Bonnick, S. L. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-499-9_11 · Cited by 2

Osteoporozda Farmakolojik Tedavinin İzlemi

... (2012) · Turkish Journal of Osteoporosis · doi:10.4274/tod.37450 · Cited by 2

Calcitonin

Silverman, S. L. (2003) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(02)00070-8 · Cited by 2

Suivi des traitements de l’ostéoporose

Lespessailles, É. (2006) · La Presse Médicale · doi:10.1016/s0755-4982(06)74852-7 · Cited by 2

Raloxifene hydrochloride (Evista® Tablet 60 mg) for postmenopausal osteoporosis: mode of action and clinical efficacy

Kobayashi, H., & Hamaya, E. (2005) · Folia Pharmacologica Japonica · doi:10.1254/fpj.125.37 · Cited by 2

Postmenopausal Osteoporosis Treatment Update

Wong, E. K. C., & Παπαϊωάννου, Α. (2018) · Current Treatment Options in Rheumatology · doi:10.1007/s40674-018-0098-y · Cited by 2

Combination Therapy for Osteoporosis: What Do the Data Show Us?

Miller, P. D. (2006) · Elsevier eBooks · doi:10.1016/b978-0-323-03437-1.50027-0 · Cited by 2

Pathophysiology and Epidemiology of Osteoporosis

Stevens, N. M., & Konda, S. R. (2020) · Springer eBooks · doi:10.1007/978-3-030-33861-9_2 · Cited by 2

Monitoring the Initial Response to Treatment

Bell, K., Craig, J. C., & Irwig, L. (2008) · doi:10.1002/9780470696323.ch6 · Cited by 2

Hormone and Exercise‐Induced Modulation of Bone Metabolism

Rosen, C. J. (2005) · doi:10.1002/9780470757826.ch28 · Cited by 2

Determinants of bone strength and clinical practice; effects of bisphosphonates

Papapoulos, S. E. (2007) · Bone · doi:10.1016/j.bone.2007.08.003 · Cited by 2

Current roles and realities of noninvasive assessment of osteoporosis

Burke, M. S. (2004) · Current Opinion in Internal Medicine · doi:10.1097/01.med.0000145446.27182.78 · Cited by 2

Lessons from osteoporosis clinical trials

Silverman, S. L. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.04.006 · Cited by 2

Meeting report from the 24th annual meeting of the American society for bone and mineral research

Black, D. M., Bouillon, R., Ducy, P. F., Miller, P. D., Papapoulos, S. E., Ralston, S. H., Ross, P. A., Schipani, E., Seeman, E., Strewler, G. J., et al. (2002) · BoneKEy-Osteovision · doi:10.1138/2002065 · Cited by 2

New Mechanistic Insights

Armas, L. A. G., & Recker, R. R. (2012) · Cited by 2

Comparison of hr-pQCT & MRTA to DXA & QUS for the Ex-vivo Assessment of Bone Strength

Ally, I. A. L. (2010) · TSpace (University of Toronto) · Cited by 2

Osteoporosis and osteopenia management in women: survey, case-referent study, and interventional exercise trial

Mekary, R. A. (2005) · doi:10.31390/gradschool_dissertations.759 · Cited by 2

Oral antiresorptive therapy

Pande, I., & Hosking, D. J. (2004) · Current Osteoporosis Reports · doi:10.1007/s11914-996-0010-9 · Cited by 2

Response to Letter to the Editor

Delmas, P. D., & Seeman, E. (2004) · Bone · doi:10.1016/j.bone.2004.08.014 · Cited by 2

Cortical bone mechanics technology signal quality maintains robustness across a range of biometric profiles

Dick, A., Stoeckel, M., Ruzzene, M., von Sadovszky, T., Simon, J. E., Clark, L. A., Warden, S. J., Manini, T. M., Lyssikatos, C., Hart, T., et al. (2025) · JBMR Plus · doi:10.1093/jbmrpl/ziaf116 · Cited by 1

Risk factors analysis for refracture after vertebroplasty in osteoporotic thoracolumbar vertebral fractures

Yang, K., Lu, C., Sun, X., Zhu, X., Shi, H., & Ding, H. (2025) · European journal of medical research · doi:10.1186/s40001-025-03499-y · Cited by 1

Monitoring DXA Measurement in Clinical Practice

Maghraoui, A. E. (2012) · InTech eBooks · doi:10.5772/30573 · Cited by 1

Testosterone Therapy for Osteoporosis in Men

Lakshman, K. M., Bhasin, S., & Araujo, A. B. (2010) · Osteoporosis in Men · doi:10.1016/b978-0-12-374602-3.00056-0 · Cited by 1

Ostéoporose : critères de diagnostic et de suivi. L’outil FRAX®. Scores radiologiques

Briot, K. (2010) · Revue du Rhumatisme Monographies · doi:10.1016/j.monrhu.2010.01.009 · Cited by 1

Adherence and Monitoring of Osteoporosis Therapy

Bartl, R., & Frisch, B. (2009) · Springer eBooks · doi:10.1007/978-3-540-79527-8_22 · Cited by 1

Evidence-based medicine and common sense: practical and ethical issues in clinical trials for osteoporosis

Heaney, R. P. (2007) · Future Rheumatology · doi:10.2217/17460816.2.1.105 · Cited by 1

Treatment and Prevention of Glucocorticoid-Induced Osteoporosis

Micheletti, R. G., Murrell, D. F., & Werth, V. P. (2015) · Springer eBooks · doi:10.1007/978-3-662-45698-9_63 · Cited by 2

One Year Zoledronic Acid Therapy In Postmenopausal Osteoporosis

(2007) · The Internet Journal of Internal Medicine · doi:10.5580/96f · Cited by 1

DISORDERS OF CALCIUM METABOLISM AND BONE MINERALIZATION

Clarke, B. L., & Khosla, S. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3291-5.50043-3 · Cited by 1

Possibilities for treatment of osteoporosis

Růžičková, O. (2017) · Interní medicína pro praxi · doi:10.36290/int.2017.039 · Cited by 1

Bone Health: Basic and Applied Bone Biology

Miedany, Y. M. E. (2022) · Springer eBooks · doi:10.1007/978-3-030-87950-1_1 · Cited by 1

Skeletal heterogeneity and the purposes of bone remodeling

PARFITT, A. M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813073-5.00030-7 · Cited by 1

Biochemical Markers of Bone Turnover

Garnero, P. (2006) · Elsevier eBooks · doi:10.1016/b978-0-323-03437-1.50017-8 · Cited by 1

Modeling and Experimental Results for Microwave Imaging of a Hip with Emphasis on the Femoral Neck

Adams, J., Serano, P. J., & Nazarian, A. (2022) · Springer eBooks · doi:10.1007/978-3-031-15451-5_10 · Cited by 1

Vertebral body density role in determining vertebral osteoporotic fracture type and its progression

Smorgick, Y., Pelleg‐Kallevag, R., Lindner, D., Anekstein, Y., Goldstein, S., & May, H. (2024) · Clinical Anatomy · doi:10.1002/ca.24219 · Cited by 1

The Benefits of Physical Activity on Climacteric Women

Bittar, S. T., de Macêdo, J. O. R., Neto, E. A. P., da Silva, H. G., Pfeiffer, P. A. D. S., Padilha, J. A., dos Santos, W. V., & de Sousa, M. D. S. C. (2017) · InTech eBooks · doi:10.5772/intechopen.68829 · Cited by 1

Physical Activity to Promote Bone Health in Adolescents

Warden, S. J., & Fuchs, R. K. (2018) · Springer eBooks · doi:10.1007/978-3-319-72880-3_4 · Cited by 2

Genetic determinants of bone mass and osteoporotic fracture

Hsu, Y., Farber, C. R., & Kiel, D. P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814841-9.00068-3 · Cited by 1

Dual x-ray absorptiometry and measurement of bone

Bonnick, S. L. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-09138-1.00044-9 · Cited by 1

Study and Prediction of Bone Strength of Rats with Different Intensity of Swimming Therapy Based on Synchrotron Radiation

Li, W., Xu, J. M., Zhao, J., Guo, H., & Sun, J. (2020) · International Conference on Biological Information and Biomedical Engineering (BIBE) · doi:10.1145/3403782.3403814 · Cited by 1

Monitoring der medikamentösen Osteoporosetherapie

Bartl, R., & Bärtl, C. (2021) · Springer eBooks · doi:10.1007/978-3-662-62528-6_23 · Cited by 1

Macroimaging

Engelke, K., Genant, H. K., & Griffith, J. F. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814841-9.00080-4 · Cited by 1

Long-term bisphosphonates for osteoporosis: An introduction

Strewler, G. J. (2005) · BoneKEy-Osteovision · doi:10.1138/20050143 · Cited by 1

How does raloxifene reduce fracture risk?

McClung, M. R. (2002) · Menopause The Journal of The North American Menopause Society · doi:10.1097/00042192-200209000-00002 · Cited by 1

Oral antiresorptive therapy

Pande, I., & Hosking, D. J. (2004) · Current Osteoporosis Reports · doi:10.1007/bf02686924 · Cited by 2

Meeting report from the 25th annual meeting of the American society for bone and mineral research

Blumsohn, A., Faccio, R., Jiang, Y., Karsenty, G., Klein, R. F., Kotowicz, M. A., Reid, I. R., Robey, P. G., Seeman, E., & Strewler, G. J. (2003) · BoneKEy-Osteovision · doi:10.1138/20030112 · Cited by 1

Bisphosphonate Therapy for the Treatment of Postmenopausal Osteoporosis

Devogelaer, J., Boutsen, Y., & Manicourt, D. H. (2005) · Aging Health · doi:10.2217/1745509x.1.3.459 · Cited by 1

Use of Alendronate After 5 Years of Treatment—Reply

Black, D. M., Schwartz, A. V., Cummings, S. R., Cauley, J. A., & Palermo, L. (2007) · JAMA · doi:10.1001/jama.297.18.1980 · Cited by 1

Genetic determinants of bone strength and fracture in humans: dreams and realities

Ferrari, S. (2003) · Osteoporosis International · doi:10.1007/s00198-003-1481-5 · Cited by 1

Hormone therapy in elderly women; a comparative study with alendronate of the effects on bone, cardiovascular risk factors, periodontal conditions and quality of life

Eviö, S. (2006) · Työväentutkimus Vuosikirja · Cited by 1

Lifestyle risk factors and bone mineral density of urban postmenopausal women in the North West Province

Ellis, C. (2013) · Cited by 1

Trabecular Microarchitecture, Endplate Failure, and the Biomechanics of Human Vertebral Fractures

Fields, A. J. (2010) · eScholarship (California Digital Library) · Cited by 1

COMPARISON OF TWO LOADING SURFACE PREPARATION METHODS ON RAT VERTEBRAL BODIES FOR COMPRESSION TESTING

Schumacher, Y. (2013) · QSpace (Queen's University Library) · Cited by 1

THE EFFECTS OF A UNIFORMLY WEIGHTED EXERCISE SUIT ON BIOMARKERS OF BONE TURNOVER IN RESPONSE TO AEROBIC EXERCISE IN POSTMENOPAUSAL WOMEN WITH LOW BONE DENSITY

Terndrup, H. F. (2016) · DigitalCommons - CalPoly (California State Polytechnic University) · doi:10.15368/theses.2016.119 · Cited by 1

Diagnostik und Therapie der Osteoporose. Teil 2. Präventive und therapeutische Massnahmen

Meier, C., Seibel, M. J., & Kraenzlin, M. (2006) · Swiss Medical Forum ‒ Schweizerisches Medizin-Forum · doi:10.4414/smf.2006.05939 · Cited by 1

Calcitonin in the Treatment of Osteoporosis

Silverman, S. L. (2006) · Elsevier eBooks · doi:10.1016/b978-0-323-03437-1.50024-5 · Cited by 1

Monitoring Changes in Bone Density

Bonnick, S. L. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-659-1_11 · Cited by 1

In Vivo Mechanical Assessment of Cortical Bone Rigidity Enhances Fracture Discrimination Beyond DXA in Postmenopausal WomenPreprint

Clark, B. C., Manini, T. M., Simon, J. E., Clark, L. A., Lyssikatos, C., & Warden, S. J. (2025) · medRxiv · doi:10.1101/2025.08.28.25334655 · Cited by 1

Treatment Strategies in Osteoporosis

Bartl, R., & Bärtl, C. (2016) · Springer eBooks · doi:10.1007/978-3-032-21885-8_23

Diet, Osteoporosis, and Fracture Prevention: The Totality of the Evidence

Heaney, R. P. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-542-2_19

Atypical osteoporotic fractures: impact on therapeutic decision making in osteoporosis.

Ish‐Shalom, S. (2014) · PubMed

Monitoring Therapy for Osteoporosis

Lewiecki, E. M. (2013) · doi:10.1002/9781118316290.ch15

Intérêt de l'évaluation systématique de la micro-architecture osseuse par technique BMA™ en complément de la densitométrie osseuse dans une population de patients fracturés

Cheriet, S. (2012) · HAL

Medikamentöse Therapie der Osteoporose

Resch, H., & Muschitz, C. (2006) · Springer eBooks · doi:10.1007/3-211-32315-5_2

The Role of Architecture and Tissue Properties in the Structural Integrity of Human Vertebral Cancellous Bone

Cole, J. H. (2007) · eCommons (Cornell University)

Is monitoring osteoporosis therapy worthwhile?

Compston, J. E. (2009) · IBMS BoneKEy · doi:10.1138/20090367

Es posible la comparaci n de f rmacos head to head en osteoporosis?

Nogués, X. (2006) · Revista Española de Enfermedades Metabólicas Óseas · doi:10.1016/s1132-8460(06)75258-8

Traitement médicamenteux des ostéoporoses post-ménopausiques et cortisoniques

Roux, C. (2002) · Revue du Rhumatisme · doi:10.1016/s1169-8330(02)00426-x

Recommandations pour le suivi des traitements antirésorptifs au cours de l’ostéoporose postménopausique

Roux, C., Garnero, P., Thomas, T., Sabatier, J., Orcel, P., & Audran, M. (2004) · Revue du Rhumatisme · doi:10.1016/j.rhum.2004.07.006

Are all bisphosphonates the same?

Lindsay, R. S. (2007) · Bone · doi:10.1016/j.bone.2007.03.001

Surrogate markers for the effect of antiresorptive therapies on non-vertebral fractures - a critique

Eastell, R. (2002) · BoneKEy-Osteovision · doi:10.1138/2002057

State-of-the-Art Pharmacometric Models in Osteoporosis

Kondic, A. G., Cabal, A., Fayad, G. N., Mehta, K., Kerbusch, T., & Post, T. M. (2014) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-1-4939-1304-6_13

Importance of reversible remodeling suppression with denosumab

Recker, R. R. (2012) · IBMS BoneKEy · doi:10.1038/bonekey.2012.51

Understanding Bone Strength

Delaney, M. F. (2006) · The Endocrinologist · doi:10.1097/01.ten.0000203584.18296.ff

Intermittent intravenous zoledronic acid increased bone mineral density in postmenopausal women

Blank, R. D. (2002) · Evidence-based obstetrics and gynecology/Evidence-based obstetrics & gynecology · doi:10.1054/ebog.2002.0084

Osteoporosis therapy in the elderly

Kiel, D. P. (2004) · Current Opinion in Internal Medicine · doi:10.1097/01.med.0000144036.50650.66

Anatomofisiología y fisiopatología de la osteoporosis

González, J. T. C., & Viera, O. B. (2007) · DOAJ (DOAJ: Directory of Open Access Journals)

Osteoporosis in the Elderly

Karnik, A. A., & Feldt, J. M. V. (2008) · Aging Health · doi:10.2217/1745509x.4.4.351

Principles of Diagnosing and Managing Postmenopausal Osteoporosis for the Podiatric Physician

McGarry, K., & Cyr, M. G. (2004) · Journal of the American Podiatric Medical Association · doi:10.7547/87507315-94-2-187

Máxima evidencia y de mejor calidad en metaanálisis de bifosfonatos para el tratamiento de la osteoporosis en mujeres posmenopáusicas

Castro, A. D. M. (2007) · Revista Española de Enfermedades Metabólicas Óseas · doi:10.1016/s1132-8460(07)73507-9

Avaliação da microarquitetura e biomecânica de ossos trabeculares normais, osteopênicos e osteoporóticos de vértebras humanas por técnicas de ensaios mecânicos, microtomografia de raios-X e homogeneização assintótica

Cesar, R. (2014) · doi:10.11606/t.18.2014.tde-09022015-113119

Monitoring patients on osteoporosis therapy

Atmaca, A. A., & Kleerekoper, M. (2007) · Future Rheumatology · doi:10.2217/17460816.2.1.73

Osteoporosis: Beyond Bone Mineral Density (Part II)

Neustadt, J. O., & Pieczenik, S. R. (2009)

The effects of discontinuing long- term alendronate therapy in a clinical practice setting Efeitos da retirada do uso prolongado de alendronato na prática clínica

da Silva, A. G., Gilberto, J., Vieira, H. R. L., Kunii, I. S., de Lana, J. M., & Lazaretti‐Castro, M. (2011)

Veränderungen der Mikroarchitektur des Knochens bei Patientinnen mit postmenopausaler Osteoporose unter unterschiedlichen Therapien in der hochauflösenden peripheren quantitativen Computertomographie

Amling, M. (2013)

The effect of antiresorptive treatment on osteopontin values in osteoporosis

Koca, İ., Göğebakan, B., İğci, Y. Z., Işık, M., Boyacı, A., Tutoğlu, A., Geyik, E., İğci, M., & Ulaşlı, M. (2014) · DergiPark (Istanbul University)

treatment: secondary analysis of trial data density after starting bisphosphonate Value of routine monitoring of bone mineral

Ensrud, K. E., Bauer, D. C., Bell, K., Hayen, A. D., Macaskill, P., & Craig, J. C. (2009)

Bone density vs bone quality: What's a clinician to do?

Act, A. (2009)

AUTOMATED SUB-MICRON RESOLUTION SERIAL BLOCK FACE IMAGING OF CANCELLOUS BONE USING EPIFLUORESCENCE MICROSCOPY

Slyfield, C. R. (2008) · OhioLink ETD Center (Ohio Library and Information Network)

A BIOMECHANICAL ANALYSIS OF APE AND HUMAN THORACIC VERTEBRAE USING QUANTITATIVE COMPUTED TOMOGRAPHY BASED FINITE ELEMENT MODELS

Loomis, D. A. (2009) · OhioLink ETD Center (Ohio Library and Information Network)

Bone mechanoadaptation and the influence of muscular action on bone across the lifespan

Ireland, A. (2026) · e-space (Manchester Metropolitan University) · doi:10.83056/mmu.32436561

Assessment of Femoral Geometric Strength in Osteoporosis Using Hip Structure Analysis

Takada, J. (2015) · Springer eBooks · doi:10.1007/978-4-431-55778-4_4

How drugs decrease fracture risk: lessons from trials.

Cummings (2002) · PubMed · Cited by 31

Risk of fracture among women who lose bone density during treatment with alendronate. The Fracture Intervention Trial

Chapurlat, R. D., Palermo, L., Ramsay, P., & Cummings, S. R. (2004) · Osteoporosis International · doi:10.1007/s00198-004-1770-7 · Cited by 133

The role of parvovirus B19 in the pathogenesis of giant cell arteritis: A preliminary evaluation

Gabriel, S. E., Espy, M. J., Erdman, D. D., Björnsson, J., Smith, T. F. A., & Hunder, G. G. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199906)42:6 · Cited by 156

Relationship Between Changes in Bone Mineral Density and Vertebral Fracture Risk Associated With Risedronate

Watts, N. B., Cooper, C. C., Lindsay, R., Eastell, R., Manhart, M. D., Barton, I. P., van Staa, T. P., & Adachi, J. D. (2004) · Journal of Clinical Densitometry · doi:10.1385/jcd:7:3:255 · Cited by 228

OP0113 Increases in bone mineral density explain the reduction in incidence of nonvertebral fractures seen with antiresorptive therapy in women with postmenopausal osteoporosis

Wasnich, R. D., Mc, H., Greenspan, S. L., Ross, P., & Miller, P. (2001) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2001.634